FREE Shipping on all US Orders
Saw palmetto vs finasteride: the honest numbers, what the 2025 clinical trials show, and when the botanical is enough — and when it isn't.
Saw palmetto inhibits the same enzyme as finasteride — 5-alpha reductase — but at 30-40% vs finasteride's 70% and dutasteride's 98%. A 2025 RCT and 2026 180-day extension both confirm significant improvements in hair density and quality with no adverse events. Here is the honest numbers, who it's enough for, and when the botanical is not the right tool.
Saw palmetto is the right class of intervention — 5-alpha reductase inhibition — at a more modest scale. For patients with mild androgenetic alopecia who want a non-prescription option, it is a reasonable choice. For moderate or advanced pattern baldness, prescription options deliver substantially better results. That is the honest summary from a dermatologist's perspective.
Saw palmetto is probably the most researched natural supplement for hair loss. It is also one of the most honestly described when you look at what the clinical evidence actually says rather than what the supplement industry claims.
Here are the honest numbers: clinical studies show saw palmetto inhibits about 30-40% of 5-alpha reductase activity — the enzyme that converts testosterone into DHT. For comparison, finasteride inhibits about 70% and dutasteride about 98% of that same enzyme.
That comparison frames everything. Saw palmetto is the right class of intervention — 5-AR inhibition — at a more modest scale. The question is not whether it works. It does, and the clinical evidence is now substantial. The question is whether the level of DHT reduction it produces is enough for your specific situation.
What the Research Shows
Five studies worth knowing — and what each one actually found.
A randomised, double-blind, placebo-controlled pilot study published in the Journal of Alternative and Complementary Medicine in 2002 tested oral saw palmetto plus beta-sitosterol in 26 men with mild-to-moderate androgenetic alopecia for five months. 60% of the saw palmetto group showed improvement versus 11% in the placebo group. Small study, but the first placebo-controlled evidence of a meaningful effect size.
A systematic review in Skin Appendage Disorders analyzed 5 RCTs and 2 prospective cohort studies. Across all studies, 60% of users reported improvement in overall hair quality, 27% in total hair count, and 83.3% demonstrated increased hair density on investigator assessment. The investigator assessment figure — 83.3% showing increased density — is the most clinically meaningful number in the saw palmetto evidence base. That is a dermatologist looking at the scalp and recording objective improvement, not a patient self-reporting.
A randomized placebo-controlled trial in 80 adults found oral saw palmetto at 320mg daily reduced hair fall by 29% and increased density by 5.17% over 16 weeks. This is a modest but statistically significant density improvement at a specific dose, in a well-designed trial — the kind of number you can give a patient who wants to know what to expect.
A 2025 90-day randomized controlled trial using a standardized Serenoa repens extract showed significant improvements in hair density and quality vs placebo. A 180-day extension — published in 2026 — showed continued improvement, with effects strengthening from 90 to 180 days and no adverse events reported. This is the freshest clinical evidence and it confirms a direction that has been consistent across two decades of trials: saw palmetto produces meaningful, dose-dependent hair density improvement when used consistently. The strengthening of effects through 180 days is particularly useful — it suggests the mechanism requires sustained use, consistent with 5-AR inhibition's mode of action.
The Honest Comparison
Saw palmetto vs finasteride vs dutasteride — the numbers side by side.
Most of the saw palmetto clinical trial data is in men. The 2020 systematic review included women but most included studies were male-predominant. The 2025 trial examined healthy men and women aged 25-65, suggesting applicability to female androgenetic alopecia — but the evidence base is not as strong for women as for men. The mechanism (5-AR inhibition reducing DHT) is relevant regardless of sex, since female pattern hair loss also involves androgenic sensitivity at the follicle.
Important point: "natural" does not mean "biologically inert." Any compound that significantly impacts DHT is capable of impacting androgen-sensitive tissues. At the doses in clinical trials, saw palmetto's safety profile has been consistently favourable — but it is not without biological effect, and women who are pregnant or trying to conceive should discuss any DHT-modifying supplement with their doctor before using it.
Who saw palmetto is enough for — and who needs more.
For patients with mild androgenetic alopecia who want a non-pharmacologic treatment strategy, are unwilling to use finasteride, or do not qualify for prescription 5-alpha reductase inhibitors — saw palmetto is a reasonable, well-tolerated choice with a two-decade evidence base. It is highly unlikely to reverse miniaturisation that has already occurred, and is best considered a mild adjunctive therapy or a prevention-focused intervention in early-stage loss.
For moderate to advanced pattern hair loss: prescription options deliver substantially better results. 30-40% 5-AR inhibition is meaningfully less than 70% or 98%. At a certain stage of androgenetic hair loss, that gap matters clinically. This is not a failure of saw palmetto — it is an honest description of what it is and isn't designed to do.
Topically applied saw palmetto — as in the Laritelle formula — provides follicle-level DHT inhibition without the systemic effects. Combined with bhringaraj's additional 5-AR inhibition and the other botanical active compounds, the formula is addressing the DHT pathway at the scalp surface from multiple botanical directions simultaneously.
Knowing the difference between 30% and 70% DHT reduction changes everything about how you use it.
Topical 5-AR inhibition — daily, at the follicle.
Saw palmetto in the Fertile Roots formula delivers follicle-level DHT inhibition without systemic effects — complementing prescription options or providing a botanical alternative for early-stage androgenic hair loss.
→ Explore Fertile Roots → Explore Hair TreatmentsScience, ritual, and botanical intelligence — delivered daily.
Each morning, one article. New research, ancient wisdom, and the honest science of hair and scalp health. Written for women who want to understand what is happening — not just what to buy.
By subscribing you agree to receive email from Laritelle Organic. Unsubscribe at any time.